What To Know
- Potrero Medical, innovator of the Accuryn Monitoring System, a sensory integrated foley catheter that provides real-time, actionable information to health care providers so they can take steps to prevent the progression of critical conditions such as acute kidney injury (AKI), announced that Vanessa Moll, MD, PhD, FCCM, FASA has joined the executive leadership team as its Chief Medical Officer (CMO).
- She has numerous publications in the field of critical care and anesthesiology and lectures nationally and internationally.
Potrero Medical, innovator of the Accuryn Monitoring System, a sensory integrated foley catheter that provides real-time, actionable information to health care providers so they can take steps to prevent the progression of critical conditions such as acute kidney injury (AKI), announced that Vanessa Moll, MD, PhD, FCCM, FASA has joined the executive leadership team as its Chief Medical Officer (CMO).
Dr. Moll brings 20 years of clinical and research experience to the company. She is a board-certified anesthesiologist and intensivist and has worked both in the US and European healthcare systems. She has numerous publications in the field of critical care and anesthesiology and lectures nationally and internationally. Dr. Moll is passionate about building capacity in anesthesiology and critical care and elevating patient care and outcomes globally.